NCT03692325 2024-10-01
Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
Dana-Farber Cancer Institute
Phase 2 Completed
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
The Oxford Dental College, Hospital and Research Center, Bangalore, India
University of Miami
National Cancer Institute (NCI)